Brazilian trial aims to replace scans with simple blood test for HPV cancers
NCT ID NCT06640283
Summary
This study is testing a new, low-cost blood test designed to detect tiny pieces of cancer DNA (ctDNA) in patients with HPV-related cervical or anal cancer after they finish radiation treatment. The goal is to see if this test can spot cancer recurrence earlier than standard scans and help doctors decide which patients might benefit from adding immunotherapy. The research aims to make this monitoring tool available within Brazil's public healthcare system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV-RELATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto do Câncer do Estado de São Paulo - ICESP
RECRUITINGSão Paulo, 01246-000, Brazil
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.